Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Crism Thera (CRTX) Share Price

Price 11.50p on 09-04-2026 at 10:20:19
Change 0.50p 4.55%
Buy 12.00p
Sell 11.00p
Last Trade: Unknown 2,500.00 at 11.50p
Day's Volume: 220,087
Last Close: 11.00p
Open: 11.00p
ISIN: VGG042401262
Day's Range 11.00p - 11.50p
52wk Range: 8.25p - 29.00p
Market Capitalisation: £5.95m
VWAP: 11.07751p
Shares in Issue: 51.74m

Crism Thera (CRTX) Latest Trades

Buy/Sell Volume Trade Prc Trade Type Trade Time
Unknown* 2,500 11.50p Ordinary
11:20:17 - 09-Apr-26
Sell* 18,274 11.40p Ordinary
10:14:24 - 09-Apr-26
Buy* 192 12.00p Ordinary
09:52:56 - 09-Apr-26
Buy* 158 12.00p SI Trade
09:52:46 - 09-Apr-26
Buy* 41 12.00p SI Trade
09:52:46 - 09-Apr-26
Buy* 200 11.50p Ordinary
09:52:43 - 09-Apr-26
Buy* 200 11.50p SI Trade
09:52:42 - 09-Apr-26
Buy* 30,000 11.38p Ordinary
09:52:28 - 09-Apr-26
Buy* 20,512 11.30p Ordinary
09:51:15 - 09-Apr-26
Sell* 49,287 10.60p Ordinary
09:04:49 - 09-Apr-26
See more Crism Thera trades

Crism Thera (CRTX) Share Price History

Time period:
to
Date Open High Low Close Volume
8th Apr 2026 (Wed) 11.00 11.00 11.00 11.00 2,822
7th Apr 2026 (Tue) 11.00 11.00 11.00 11.00 53,419
6th Apr 2026 (Mon) 11.00 11.00 11.00 11.00 0
3rd Apr 2026 (Fri) 11.00 11.00 11.00 11.00 0
2nd Apr 2026 (Thu) 11.25 11.25 11.00 11.00 637,751
1st Apr 2026 (Wed) 11.75 11.75 11.75 11.75 27,699
31st Mar 2026 (Tue) 11.75 11.75 11.75 11.75 39,225
30th Mar 2026 (Mon) 11.75 11.75 11.75 11.75 4,590
27th Mar 2026 (Fri) 11.75 11.75 11.75 11.75 98,096
26th Mar 2026 (Thu) 11.25 11.75 11.25 11.75 222,010
25th Mar 2026 (Wed) 12.25 12.25 11.00 11.25 411,258
24th Mar 2026 (Tue) 12.75 12.75 12.75 12.75 11,934
23rd Mar 2026 (Mon) 13.50 13.50 12.75 12.75 163,642
20th Mar 2026 (Fri) 13.50 13.50 13.50 13.50 99,106
19th Mar 2026 (Thu) 13.75 13.75 13.50 13.50 226,504
18th Mar 2026 (Wed) 14.50 14.50 13.75 13.75 375,025
17th Mar 2026 (Tue) 12.50 14.50 12.50 14.50 2,234,227
16th Mar 2026 (Mon) 11.75 12.00 11.75 12.00 208,195
13th Mar 2026 (Fri) 12.00 12.00 11.75 11.75 87,119
12th Mar 2026 (Thu) 12.00 12.00 12.00 12.00 5,445
11th Mar 2026 (Wed) 12.00 12.00 12.00 12.00 396
10th Mar 2026 (Tue) 12.00 12.00 12.00 12.00 294,134
9th Mar 2026 (Mon) 12.50 12.50 12.00 12.00 123,345
See more Crism Thera price history

Crism Thera (CRTX) Regulatory News

Date Source Headline
2nd Apr 2026 7:00 am RNS Board Changes
25th Mar 2026 7:00 am RNS Phase 2 Clinical Trial Progress Update
17th Mar 2026 7:00 am RNS Awarding of Orphan Drug Designation by the FDA
17th Mar 2026 7:00 am RNS Awarding of Orphan Drug Designation by the FDA
20th Jan 2026 7:00 am RNS Japanese Patent Grant
9th Jan 2026 7:00 am RNS Results of Shareholder Analysis
15th Dec 2025 2:29 pm RNS Result of Retail Offer
10th Dec 2025 7:25 am RNS Retail Offer
10th Dec 2025 7:00 am RNS Placing of £1,000,000
27th Nov 2025 7:00 am RNS Holding(s) in Company
See more Crism Thera regulatory news

Crism Thera (CRTX) Share News

TRADING UPDATES: RWS launches AI offering; SulNOx patent wins

25th Mar 2026 16:53

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Wednesday and not separately reported by Alliance News: Read More

WINNERS & LOSERS: Volex beats consensus; Asos backs outlook

25th Mar 2026 11:10

(Alliance News) - The following are the leading risers and fallers among London Main Market small-cap and AIM stocks on Wednesday. Read More

AIM WINNERS & LOSERS: CRISM rises; Intercede warns on earnings miss

17th Mar 2026 11:00

(Alliance News) - The following stocks are the leading risers and fallers on AIM on Tuesday. Read More

TRADING UPDATES: Netcall acquires Jadu for up to GBP19 million

10th Dec 2025 16:16

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Wednesday and not separately reported by Alliance News: Read More

CRISM reports "significant" preclinical data for prostate cancer drug

14th Oct 2025 16:50

(Alliance News) - CRISM Therapeutics Corp said on Tuesday that preclinical studies show that its ChemoSeed drug delivery platform could "could substantially enhance" the efficacy of docetaxel in the treatment of prostate cancer. Read More

See more Crism Thera news
FTSE 100 Latest
Value10,572.57
Change-36.31

Login to your account

Forgot Password?

Not Registered